Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 25 06:30 ET

Express News | Zura Bio Ltd - Trial Is Expected to Initiate in Q4 2024

ReutersNov 14 16:30 ET

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults With Systemic Sclerosis

BusinesswireNov 14 16:30 ET

H.C. Wainwright Maintains Zura Bio(ZURA.US) With Hold Rating, Maintains Target Price $5

Moomoo NewsNov 11 07:34 ET · Ratings

Cautious Outlook on Zura Bio: Neutral Rating Due to Clinical Challenges and Financial Uncertainty

TipRanksNov 11 06:36 ET · Ratings

Chardan Capital Maintains Zura Bio(ZURA.US) With Buy Rating, Cuts Target Price to $12

Moomoo NewsNov 9 09:31 ET · Ratings